Clear cell endometrial carcinoma and the TCGA classification
- PMID: 31433862
- DOI: 10.1111/his.13976
Clear cell endometrial carcinoma and the TCGA classification
Keywords: PROMISE; cancer; endometrium; risk assessment; treatment.
References
-
- Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013; 497; 67-73.
-
- Murali R, Davidson B, Fadare O et al. High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int. J. Gynecol. Pathol. 2019; 38(Suppl. 1); S40-S63.
-
- Hoang LN, McConechy MK, Meng B et al. Targeted mutation analysis of endometrial clear cell carcinoma. Histopathology 2015; 66; 664-674.
-
- Stelloo E, Bosse T, Nout RA et al. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Mod. Pathol. 2015; 28; 836-844.
-
- Le Gallo M, Rudd ML, Urick ME et al. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing. Cancer 2017; 123; 3261-268.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
